Author:
Klitgaard Thomas,Nielsen Tina G.
Subject
Pharmacology (medical),Pharmacology
Reference30 articles.
1. Factor VIIa for correction of traumatic coagulopathy;Dutton;J Trauma,2004
2. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients. Two parallel randomized, placebo-controlled, double-blind clinical trials;Boffard;J Trauma,2005
3. 3 Novo Nordisk [http://www.novonordisk.com/]. Denmark: Phase 3 stroke trial shows that NovoSeven® reduces bleeding in the brain, but does not improve long-term clinical outcomes. Available at http://www.novonordisk.com/press/sea/sea.asp?sNewsTypeGUID=&lMonth=2&lYear=2007&sLanguageCode=en-GB&sSearchText=&sShowNewsItemGUID=0cfc120c-f013-4ad6-9130-55227465e3e8&sShowLanguageCode=en-GB (Updated 26 February 2007; last accessed 21 May 2007).
4. Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force;Martinowitz;J Thromb Haemost,2005
5. Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding - a European perspective;Vincent;Crit Care,2006
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献